Home > Press > Shrink Nanotechnologies enters into exclusive worldwide licensing agreement with Corning for modular microfluidic system
![]() |
Abstract:
Shrink Nanotechnologies Inc (OTCBB: INKN.ob), a nanotechnology company developing products and licensing opportunities, has entered into a licensing agreement with Corning Incorporated (NYSE:GLW), a speciality glass abs ceramic company.
Under the terms of the licensing agreement, announced on Friday, in exchange for a commercial royalty Shrink retains an exclusive right to use and sublicense Corning's patent-pending modular microfluidic system for at least eight years.
The patent-pending Corning modular microfluidic system has been widely published and has reportedly generated significant interest from commercial and academic interests since it was first published in 2008 in Lab on a Chip, an academic journal.
This system is claimed to be the world's first fully functional plug and play modular microfluidics system that truly allows for integrated high PSI connectors, electronics and pumps. This new "Plug and Play" integrated system offers researchers new tools to rapidly build next generation biosensors and immunodiagnostic devices.
Shrink said that it intends to develop this system as a premium microfluidic product offering throughout North America, Europe and Asia.
####
For more information, please click here
Contacts:
Shrink Nanotechnologies, Inc.
2038 Corte Del Nogal, Suite 110
Carlsbad, California 92011
Phone: (760) 804-8844
Fax: (760) 804-8845
Email:
Copyright © Shrink Nanotechnologies
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Sensors
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |